Healthcare - Biotechnology - NASDAQ - US
$ 1.8
-7.22 %
$ 53.4 M
Market Cap
-0.95
P/E
BALANCE SHEET
103 M
ASSETS
12 M
LIABILITIES
90.6 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Immuneering Corporation
| Current Assets | 89.1 M |
| Cash & Short-Term Investments | 85.7 M |
| Receivables | 0 |
| Other Current Assets | 3.42 M |
| Non-Current Assets | 13.5 M |
| Long-Term Investments | 0 |
| PP&E | 5.4 M |
| Other Non-Current Assets | 8.1 M |
| Current Liabilities | 7.85 M |
| Accounts Payable | 2.11 M |
| Short-Term Debt | 300 K |
| Other Current Liabilities | 5.43 M |
| Non-Current Liabilities | 4.16 M |
| Long-Term Debt | 4.16 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 59.4 | 72.6 | 74.9 | 37.1 | 13.8 |
| Short Term Investments | 26.3 | 32.9 | 74.3 | 0 | 0 |
| Receivables | 0 | 12.4 K | 0.2 | 0.5 | 0.2 |
| Inventory | 0 | 1 | 0 | 0 | 0 |
| Other Current Assets | 3.4 | 3.2 | 2.9 | 0.1 | 71.2 K |
| Total Current Assets | 89.1 | 108.7 | 152.3 | 37.7 | 14.1 |
| PP&E | 5.4 | 5.8 | 6.1 | 0.7 | 35.3 K |
| Intangible Assets | 0.4 | 0.4 | 0.4 | 0 | 0 |
| Goodwill | 6.7 | 6.7 | 6.7 | 0 | 0 |
| Long Term Investments | 0 | 0 | 1.0 | 0 | 0 |
| Other Long Term Assets | 1.0 | 0.7 | 0.1 | 31.9 K | 21.8 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 102.6 | 122.4 | 166.7 | 38.4 | 14.1 |
| LIABILITIES | |||||
| Accounts Payable | 2.1 | 3.2 | 1.4 | 1.5 | 0.3 |
| Short Term Debt | 0.3 | 0.4 | 0.3 | 76.3 K | 0 |
| Other Current Liabilities | 5.4 | 4.5 | 4.0 | 0.7 | 0.2 |
| Total Current Liabilities | 7.8 | 8.1 | 5.6 | 2.3 | 0.5 |
| Long Term Debt | 4.2 | 4.5 | 5.1 | 0.5 | 16.6 |
| Deferred Tax Income | 0 | 0 | 0 | 46.3 K | 21.8 K |
| Other Liabilities | 0 | 0 | 0 | 58.1 | 3.5 |
| Total Liabilities | 12.0 | 12.5 | 10.7 | 60.9 | 20.6 |
| EQUITY | |||||
| Common Stock | 29.3 K | 26.4 K | 26.3 K | 4.95 K | 4.95 K |
| Retained Earnings | (163.3) | (109.8) | (59.3) | (25.7) | (8.7) |
| Other Accumulative Comprehensive Income/Loss | 778 | 30.1 K | 49 K | (58.1) | (16.6) |
| Total Equity | 90.6 | 109.9 | 156.0 | (22.5) | (6.5) |
| Total Liabilities and Equity | 102.6 | 122.4 | 166.7 | 38.4 | 14.1 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 28.4 | 26.4 | 26.3 | 25.5 | 25.5 |